Clinical trial
A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation
NCT04338958 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase-II Clinical Trial for First Line Treatment of Stage II/III Covid-19 Patients to Treat Hyperinflammation
- Lead sponsor
- University of Jena
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 22, 2020
- Completion date
- July 15, 2021
- Enrollment
- 193 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.